M. F. Abdelmalek, A. Humar, F. Stickel, P. Andreone, A. Pascher, E. Barroso, G. W. Neff, D. Ranjan, L. T. Toselli, E. J. Gane, J. Scarola, R. Goldberg-Alberts, E. S. Maller, C.-M. Lo and for the Sirolimus Liver Conversion Trial Study Group Sirolimus Conversion Regimen Versus Continued Calcineurin Inhibitors in Liver Allograft Recipients: A Randomized Trial American Journal of Transplantation 12
Version of Record online: 10 JAN 2012 | DOI: 10.1111/j.1600-6143.2011.03919.x
Conversion from calcineurin inhibitor to sirolimus-based immunosuppression for preservation of renal function in liver transplant recipients shows no demonstrable benefit at one year. See editorial by McKenna and Trotter on page 521.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field